340B strategy collection
340B supports access to care across a wide range of covered entities, care models, and pharmacy partnerships. It also creates important considerations for organizations that support, partner with, or invest in 340B-enabled models. Protecting and strengthening that value takes coordinated strategy across pharmacy, finance, and clinical operations, with clear visibility into eligibility risk and changing program requirements. In this collection, we examine how organizations are building sustainable strategies to protect 340B value, strengthen program resilience, and sustain access for the communities they serve.
Medicaid cuts and 340B: What health systems need to know now
Medicaid cuts under H.R. 1 threaten DSH days and 340B eligibility. We discuss the implications and steps health systems can take now to protect their margin and mission.
Federal policymaking is reshaping the 340B environment as health systems prepare for 2027
As multiple new 340B policies could coincide in 2027, providers face impacts to their eligibility, reimbursement levels, cash flow, and administrative burdens. We discuss implications and next steps.
Maximize 340B program value
Chartis looks for opportunity across system pharmacy offices, ambulatory operations, 340B programs, and the revenue cycle to contain costs and grow revenue.